Clinical Trial

WE-TRUST (Workflow Optimization to Reduce Time to Endovascular Reperfusion for Ultra-fast Stroke Treatment)

Recruiting
View on ClinicalTrials.gov →
Summary
The WE-TRUST study is a multi-center randomized clinical trial to assess the impact of a Direct to Angio Suite (DTAS) workflow on stroke patient outcomes.
Protocol Amendment History 19 amendments
This ClinicalTrials.gov record has been amended 19 times since 2021-01-07; most recent amendment 2026-03-03.
Status change: Suspended → Recruiting 2022-06-01
Status change: Recruiting → Suspended 2022-03-21
Status change: Not Yet Recruiting → Recruiting 2021-07-07
Trial Details
NCT Number NCT04701684
Lead Sponsor Philips Clinical & Medical Affairs Global
Conditions Stroke, Acute
Enrollment 594 participants
Start Date 2021-06-23
Primary Completion 2027-04-01 (estimated)
Study Completion 2027-04-01 (estimated)
Updated on ClinicalTrials.gov 2026-03-05